Watchlist Price Alert

Haemonetics Corporation (HAE)

NYSE: HAE · Real-Time Price · USD

69.25

1.24 (1.82%)

At close: May 09, 2025, 1:08 PM

Dividends

No dividend history available for Haemonetics Corporation.

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Full Definition

Related Stocks

Company	Dividend Yield
Alcon	0.35%
ResMed	0.86%
The Cooper Companies	0.02%
West Pharmaceutical Services	0.39%
Aptar	1.21%
Teleflex Incorporated	0.97%

Dividend Rankings

HAE News

18 hours ago · Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates - zacks.com
1 day ago · Gear Up for Haemonetics (HAE) Q4 Earnings: Wall Street Estimates for Key Metrics - zacks.com
1 week ago · Haemonetics (HAE) Earnings Expected to Grow: Should You Buy? - zacks.com
1 week ago · 4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates - zacks.com
1 week ago · New Harris Poll findings reveal HAE patients are unsatisfied with current prophylactic treatment options, with over 90% interested in trying new therapies - businesswire.com
1 month ago · KalVista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan - businesswire.com
1 month ago · KalVista Pharmaceuticals Announces Early Completion of Enrollment in KONFIDENT-KID Pediatric HAE Trial - businesswire.com
1 month ago · Is it Apt to Retain HAE Stock in Your Portfolio for Now? - zacks.com
2 months ago · Astria Therapeutics: A High-Conviction Bet On HAE - seekingalpha.com